CervoMed Inc. Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent
CervoMed Inc. (CRVO) reported Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent of 90.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent · last filed 2026-08-07
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for the quarter ending 2026-03-31 was 90.00%, a 0.00% change year-over-year.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for the quarter ending 2025-03-31 was 90.00%, a 0.00% change year-over-year.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for the quarter ending 2024-03-31 was 90.00%, a 0.00% change year-over-year.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for the quarter ending 2023-03-31 was 90.00%, a 0.00% change year-over-year.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2025 was 90.00%, a 0.00% change from fiscal 2024.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2024 was 90.00%, a 0.00% change from fiscal 2023.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2023 was 90.00%, a 0.00% change from fiscal 2022.
- CervoMed Inc. defined contribution plan, maximum annual contributions per employee, percent for fiscal 2022 was 90.00%, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 3 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 6 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 9 month | Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 90.00% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 90.00% 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 90.00% 10-K · filed 2026-03-13 | |||
| 2025-09-30 | 90.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 90.00% 10-Q · filed 2025-08-08 | |||
| 2025-03-31 | 90.00% 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 90.00% 10-K · filed 2025-03-17 | |||
| 2024-09-30 | 90.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 90.00% 10-Q · filed 2024-08-09 | |||
| 2024-03-31 | 90.00% 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 90.00% 10-K · filed 2024-03-29 | |||
| 2023-09-30 | 90.00% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 90.00% 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | 90.00% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 90.00% 10-K · filed 2023-03-24 | |||
| 2022-09-30 | 90.00% 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 90.00% 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | 90.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 90.00% 10-K · filed 2022-03-18 | |||
| 2021-09-30 | 90.00% 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | 90.00% 10-Q · filed 2021-08-11 | |||
| 2021-03-31 | 90.00% 10-Q · filed 2021-05-07 | |||
| 2020-12-31 | 90.00% 10-K · filed 2021-03-17 | |||
| 2020-09-30 | 90.00% 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 90.00% 10-Q · filed 2020-08-07 | |||
| 2020-03-31 | 90.00% 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 90.00% 10-K · filed 2020-03-17 | |||
| 2018-12-31 | 90.00% 10-K · filed 2019-03-19 | |||
| 2017-12-31 | 90.00% 10-K · filed 2018-04-02 | |||
| 2016-12-31 | 90.00% 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |